The largest database of trusted experimental protocols

2 protocols using ab134155

1

Antibody Modification and DNA Conjugation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fourteen antibodies, including antibodies specific to c-Myc (bs-4963R,
Bioss Inc., US), vimentin (bs-0756R, Bioss Inc., US), Oct4 (bs-1111R, Bioss
Inc., US), POLRMT (489004 Pab, USBiological, US), PARP1 (LS-C745005, LifeSpan
Biosciences Inc., US), ARV7 splice variant antibody (31-1109-00, RevMAb
Biosciences, US), BCR-ABL1 (ab187831, Abcam, US), BRAFv600E (31-1042-00, RevMAb
Biosciences, US), TrkA (ab76291, Abcam, US), TrkB (ab134155, Abcam, US), BRCA2
(N-terminus specific, ab75335, Abcam, US), and BRCA2 (C-terminus specific,
ARG10523, Arigo Biolaboratories Corp., US), pan cytokeratin (bs-1712R, Bioss
Inc., US), and KRAS 2B (16155-1-AP, Proteintech, US) were first modified with
streptavidin using a streptavidin conjugation kit (Abcam, US), according to the
manufacturer’s protocol. Briefly, 100 μL of the antibody solution
(1 mg mL−1) were gently shaken with 10 μL of the
activator. Afterward, the activated antibodies were incubated with 33 μg
streptavidin overnight at 4°C. Next, 10 μL of the quencher were
added to stop the reaction. Then, 80 μL of the biotin-labeled DNA (1 mg
mL−1) were added and the mixture was incubated at room
temperature for 30 min. Finally, the solution was stored at 4°C until
use.
+ Open protocol
+ Expand
2

Protein Expression Analysis in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
After the total proteins were extracted from cells in each group, the protein concentration was detected using the BCA Protein Assay Kit (Beyotime: P0012), and the samples were added with 5× electrophoresis buffer according to the proportion and placed in a metal bath (100° C) for 10 min. Next, the protein samples were loaded (20 μg/well), separated by SDS-PAGE, and transferred onto a PVDF membrane. After being blocked with 5% skim milk powder (OXOID: LP0031B) or 5% Fatty Acid Free BSA (WarBio: M9203), the membrane was incubated with primary antibodies against cyclinD1 (Abcam: ab16663, 1:200), cyclinA2 (Abcam: ab181591, 1:2,000), proliferating cell nuclear antigen (PCNA) (Abcam: ab29, 1:1,000), matrix metalloproteinase 2 (MMP2) (Abcam: ab92536, 1:1,000), MMP3 (Abcam: ab52915, 1:1,000), MMP9 (Abcam: ab76003, 1:1,000), BDNF (Abcam: ab108319, 1:1,000), phosphorylated tropomyosin kinase receptor B (p-TrkB) (Abcam: ab229908, 1:1,000), total TrkB (t-TrkB) (Abcam: ab134155, 1:1,000), p-ERK1/2 (Abcam: ab184669, 1:10,000), t-ERK1/2 (Abcam: ab17942, 1:1,000) and GAPDH (Abcam: ab8245, 1:5,000) at 4° C overnight. The next day, the membrane was rinsed and incubated with the secondary antibody (Abcam: ab97080, 1:5,000) at room temperature for 1 h. Afterwards, the membrane was rinsed and the proteins were visualized using ECL reagent, followed by statistical analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!